|
|
|
|
| LEADER |
02990nam a2200349 u 4500 |
| 001 |
EB001839239 |
| 003 |
EBX01000000000000001003228 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 020 |
|
|
|a 9780309455084
|
| 020 |
|
|
|a 0309455081
|
| 100 |
1 |
|
|a Markowitz-Shulman, Ariel
|
| 245 |
0 |
0 |
|a Exploring the state of the science in the field of regenerative medicine
|h Elektronische Ressource
|b challenges of and opportunities for cellular therapies : proceedings of a workshop
|c Ariel Markowitz-Shulman, Erin Hammers-Forstag, Siobhan Addie, and Sarah H. Beachy, rapporteurs ; Forum on Regenerative Medicine, Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
|
| 260 |
|
|
|a Washington, DC
|b National Academies Press
|c 2017, [2017]
|
| 300 |
|
|
|a 1 PDF file (xxi,114 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Health Policy
|
| 653 |
|
|
|a Regenerative Medicine / methods
|
| 653 |
|
|
|a Cell- and Tissue-Based Therapy / methods
|
| 653 |
|
|
|a Patient Care
|
| 700 |
1 |
|
|a Forstag, Erin Hammers
|e [rapporteur]
|
| 700 |
1 |
|
|a Addie, Siobhan
|e [rapporteur]
|
| 700 |
1 |
|
|a Beachy, Sarah H.
|e [rapporteur]
|
| 710 |
2 |
|
|a National Academies of Sciences, Engineering, and Medicine (U.S.)
|b Forum on Regenerative Medicine
|
| 710 |
2 |
|
|a State of the Science in the Field of Regenerative Medicine: Challenges of and Opportunities for Cellular Therapies (Workshop) (2016, Washington, D.C.)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK425081/pdf/Bookshelf_NBK425081.pdf
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Regenerative medicine holds the potential to create living, functional cells and tissues that can be used to repair or replace those that have suffered potentially irreparable damage due to disease, age, traumatic injury, or genetic and congenital defects. The field of regenerative medicine is broad and includes research and development components of gene and cell therapies, tissue engineering, and non-biologic constructs. Although regenerative medicine has the potential to improve health and deliver economic benefits, this relatively new field faces challenges to developing policies and procedures to support the development of novel therapies are both safe and effective. In October 2016, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop with the goal of developing a broad understanding of the opportunities and challenges associated with regenerative medicine cellular therapies and related technologies. Participants explored the state of the science of cell-based regenerative therapies within the larger context of patient care and policy. This publication summarizes the presentations and discussions from the workshop
|